Literature DB >> 34341748

Quantitative whole-body MR imaging for assessment of tumor burden in patients with multiple myeloma: correlation with prognostic biomarkers.

Mengtian Sun1, Jingliang Cheng1, Cuiping Ren1, Yong Zhang1, Yinhua Li1, Ying Li1, Suping Zhang2.   

Abstract

BACKGROUND: To assess the quantification of tumor burden in multiple myeloma (MM) patients using whole-body magnetic resonance imaging (MRI) and to identify the correlation between MRI parameters and prognostic biomarkers.
METHODS: We retrospectively analyzed 95 newly diagnosed MM patients treated at our hospital from June 2018 to March 2020. All patients underwent whole-body MRI examination, including diffusion-weighted whole-body imaging with background body signal suppression (DWIBS), modified Dixon chemical-shift imaging (mDIXON), and short TI inversion recovery (STIR) sequences. The MRI presentation was used to determine MM infiltration patterns and calculate apparent diffusion coefficient (ADC) and a fat fraction (FF). The one-way ANOVA and Kruskal-Wallis test were used to compare the differences of these values between DS, ISS, and R-ISS stages in different MM infiltration patterns. Spearman correlation test was used for correlation analysis of ADC and FF against prognostic biomarkers, and two independent sample t-test was used to evaluate the differences of ADC and FF in different free light-chain ratio groups.
RESULTS: The MRI presentation was classified into normal pattern (36 patients; 37.9%), diffuse (27 patients; 28.4%), and focal (32 patients; 33.7%) infiltration patterns. Statistically significant ADC and FF differences between different DS, ISS, and R-ISS stages were observed in normal/diffuse infiltration patterns but not in focal infiltration patterns. The ADC and FF of the normal/diffuse infiltration pattern showed correlations with hemoglobin, β2-microglobulin, bone marrow plasma cells, flow cytometry of bone marrow cells, and serum monoclonal protein. In contrast, ADC in focal infiltration patterns was negatively correlated with β2-microglobulin and C-reactive protein. The FF of patients with a normal/diffuse infiltration pattern was higher in the low free light-chain ratio group than that in the high free light-chain ratio group (P=0.023).
CONCLUSIONS: Our observations indicate that quantitative whole-body functional MRI examination may serve as an effective complement to imaging diagnosis based on morphology and provide further information on the tumor burden of patients with MM. 2021 Quantitative Imaging in Medicine and Surgery. All rights reserved.

Entities:  

Keywords:  Multiple myeloma (MM); diffusion-weighted whole-body imaging with background body signal suppression (DWIBS); magnetic resonance imaging (MRI); modified Dixon chemical-shift imaging (mDIXON); tumor burden

Year:  2021        PMID: 34341748      PMCID: PMC8245954          DOI: 10.21037/qims-20-1361

Source DB:  PubMed          Journal:  Quant Imaging Med Surg        ISSN: 2223-4306


  37 in total

1.  Proton density fat fraction (PDFF) MR imaging for differentiation of acute benign and neoplastic compression fractures of the spine.

Authors:  Frederic Carsten Schmeel; Julian Alexander Luetkens; Simon Jonas Enkirch; Andreas Feißt; Christoph Hans-Jürgen Endler; Leonard Christopher Schmeel; Peter Johannes Wagenhäuser; Frank Träber; Hans Heinz Schild; Guido Matthias Kukuk
Journal:  Eur Radiol       Date:  2018-06-01       Impact factor: 5.315

2.  NCCN Guidelines Insights: Multiple Myeloma, Version 3.2016.

Authors:  Kenneth C Anderson; Melissa Alsina; Djordje Atanackovic; J Sybil Biermann; Jason C Chandler; Caitlin Costello; Benjamin Djulbegovic; Henry C Fung; Cristina Gasparetto; Kelly Godby; Craig Hofmeister; Leona Holmberg; Sarah Holstein; Carol Ann Huff; Adetola Kassim; Amrita Y Krishnan; Shaji K Kumar; Michaela Liedtke; Matthew Lunning; Noopur Raje; Frederic J Reu; Seema Singhal; George Somlo; Keith Stockerl-Goldstein; Steven P Treon; Donna Weber; Joachim Yahalom; Dorothy A Shead; Rashmi Kumar
Journal:  J Natl Compr Canc Netw       Date:  2016-04       Impact factor: 11.908

Review 3.  Role of MRI for the diagnosis and prognosis of multiple myeloma.

Authors:  Andrea Baur-Melnyk; Sonja Buhmann; H R Dürr; Maximilian Reiser
Journal:  Eur J Radiol       Date:  2005-07       Impact factor: 3.528

4.  The presence of large focal lesions is a strong independent prognostic factor in multiple myeloma.

Authors:  Leo Rasche; Edgardo J Angtuaco; Terri L Alpe; Grant H Gershner; James E McDonald; Rohan S Samant; Manoj Kumar; Rudy Van Hemert; Joshua Epstein; Shayu Deshpande; Ruslana Tytarenko; Shmuel Yaccoby; Jens Hillengass; Sharmilan Thanendrarajan; Carolina Schinke; Frits van Rhee; Maurizio Zangari; Brian A Walker; Bart Barlogie; Gareth J Morgan; Faith E Davies; Niels Weinhold
Journal:  Blood       Date:  2018-05-21       Impact factor: 22.113

5.  Serum Free Light Chain Assessment Early After Stem Cell Transplantation as a Prognostic Factor in Multiple Myeloma.

Authors:  Kevin Barley; Sharon Tindle; Emilia Bagiella; Sundar Jagannath; Ajai Chari
Journal:  Clin Lymphoma Myeloma Leuk       Date:  2015-06-06

6.  A magnetic resonance imaging-based prognostic scoring system to predict outcome in transplant-eligible patients with multiple myeloma.

Authors:  Elias K Mai; Thomas Hielscher; Jost K Kloth; Maximilian Merz; Sofia Shah; Marc S Raab; Michaela Hillengass; Barbara Wagner; Anna Jauch; Dirk Hose; Marc-André Weber; Stefan Delorme; Hartmut Goldschmidt; Jens Hillengass
Journal:  Haematologica       Date:  2015-03-20       Impact factor: 9.941

Review 7.  Functional and molecular MRI of the bone marrow in multiple myeloma.

Authors:  Vassilis Koutoulidis; Nickolas Papanikolaou; Lia A Moulopoulos
Journal:  Br J Radiol       Date:  2018-02-13       Impact factor: 3.039

8.  A clinical staging system for multiple myeloma. Correlation of measured myeloma cell mass with presenting clinical features, response to treatment, and survival.

Authors:  B G Durie; S E Salmon
Journal:  Cancer       Date:  1975-09       Impact factor: 6.860

9.  Tumor load in patients with multiple myeloma: β2-microglobulin levels versus whole-body MRI.

Authors:  Melvin D'Anastasi; Mike Notohamiprodjo; Gerwin P Schmidt; Hans-Roland Dürr; Maximilian Ferdinand Reiser; Andrea Baur-Melnyk
Journal:  AJR Am J Roentgenol       Date:  2014-10       Impact factor: 3.959

10.  Treatment of multiple myeloma with high-risk cytogenetics: a consensus of the International Myeloma Working Group.

Authors:  Pieter Sonneveld; Hervé Avet-Loiseau; Sagar Lonial; Saad Usmani; David Siegel; Kenneth C Anderson; Wee-Joo Chng; Philippe Moreau; Michel Attal; Robert A Kyle; Jo Caers; Jens Hillengass; Jesús San Miguel; Niels W C J van de Donk; Hermann Einsele; Joan Bladé; Brian G M Durie; Hartmut Goldschmidt; María-Victoria Mateos; Antonio Palumbo; Robert Orlowski
Journal:  Blood       Date:  2016-03-21       Impact factor: 22.113

View more
  1 in total

1.  The Apparent Diffusion Coefficient of Diffusion-Weighted Whole-Body Magnetic Resonance Imaging Affects the Survival of Multiple Myeloma Independently.

Authors:  Bei Zhang; Bingyang Bian; Yanjiao Zhang; Li Zhang; Rongkui Zhang; Jiping Wang
Journal:  Front Oncol       Date:  2022-03-04       Impact factor: 6.244

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.